Association between cognitive impairment and bone mineral density in postmenopausal women

Menopause

Volumn 19, Issue 6, 2012, Pages 636-641

  Lee, Dong Yun ^a   Na, Duk L ^a   Seo, Sang Won ^a   Chin, Juhee ^a   Lim, Seung Jae ^a   Choi, Dooseok ^a   Min, Yong Ki ^a   Yoon, Byung Koo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Alzheimer disease; Bone mineral density; Cognitive impairment; Mild cognitive impairment; Subjective memory impairment

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BONE DENSITY; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRAGILITY FRACTURE; HIP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; POSTMENOPAUSE; SPINE RADIOGRAPHY;

AGED; ALZHEIMER DISEASE; BONE DENSITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MEMORY DISORDERS; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE;

EID: 84862776789     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31823dbec7     Document Type: Article

References (48)

1. Lobo A, Launer LJ, Fratiglioni L, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000; 54:S4-S9.
2. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.
3. Grundman M, Petersen RC, Ferris SH, et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 2004;61:59-66.
4. Barrett AM. Probable Alzheimer's disease: gender-related issues. J Gend Specif Med 1999;2:55-60.
5. Luetters C, Huang MH, Seeman T, et al. Menopause transition stage and endogenous estradiol and follicle-stimulating hormone levels are not related to cognitive performance: cross-sectional results from the Study of Women's Health Across the Nation (SWAN). J Womens Health (Larchmt) 2007;16:331-344.
6. Henderson VW, Guthrie JR, Dudley EC, Burger HG, Dennerstein L. Estrogen exposures and memory at midlife: a population-based study of women. Neurology 2003;60:1369-1371.
7. Fuh JL, Wang SJ, Lee SJ, Lu SR, Juang KD. A longitudinal study of cognition change during early menopausal transition in a rural community. Maturitas 2006;53:447-453.
8. Herlitz A, Thilers P, Habib R. Endogenous estrogen is not associated with cognitive performance before, during, or after menopause. Menopause 2007;14:425-431.
9. Rocca WA, Bower JH, Maraganore DM, et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007;69:1074-1083.
10. Sherwin BB, Phillips S. Estrogen and cognitive functioning in surgically menopausal women. Ann N Y Acad Sci 1990;592:474-475.
11. Tan ZS, Seshadri S, Beiser A, et al. Bone mineral density and the risk of Alzheimer disease. Arch Neurol 2005;62:107-111.
12. Yaffe K, Browner W, Cauley J, Launer L, Harris T. Association between bone mineral density and cognitive decline in older women. J Am Geriatr Soc 1999;47:1176-1182.
13. Zhang Y, Seshadri S, Ellison RC, Heeren T, Felson DT. Bone mineral density and verbal memory impairment: Third National Health and Nutrition Examination Survey. Am J Epidemiol 2001;154:795-802.
14. Lui LY, Stone K, Cauley JA, Hillier T, Yaffe K. Bone loss predicts subsequent cognitive decline in older women: the study of osteoporotic fractures. J Am Geriatr Soc 2003;51:38-43.
15. Brownbill RA, Ilich JZ. Cognitive function in relation with bone mass and nutrition: cross-sectional association in postmenopausal women. BMC Womens Health 2004;4:2.
16. Seo SW, Im K, Lee JM, et al. Cortical thickness in single-versus multiple-domain amnestic mild cognitive impairment. Neuroimage 2007; 36:289-297.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944.
18. Kang Y, Na DL. Seoul Neuropsychological Screening Battery. Incheon, Korea: Human Brain Research & Consulting Co., 2003.
19. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
20. Lynch CA, Walsh C, Blanco A, et al. The clinical dementia rating sum of box score in mild dementia. Dement Geriatr Cogn Disord 2006;21: 40-43.
21. Folstein MF, Folstein SE, McHugh PR. FMini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
22. Bravo G, Hebert R. Age-and education-specific reference values for the Mini-Mental and modified Mini-Mental State Examinations derived from a non-demented elderly population. Int J Geriatr Psychiatry 1997; 12:1008-1018.
23. Kang Y. A normative study of the Korean-Mini Mental State Examination (K-MMSE) in the elderly. Korean J Psychol 2006;25:1-12.
24. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982;17:37-49.
25. Jung IK, Kwak DI, Shin DK, Lee MS, Lee HS, Kim JY. A reliability and validity study of geriatric depression scale. J Korean Neuropsychiatr Assoc 1997;36:103-111.
26. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J 1965;14:61-65.
27. Kanis JA, Oden A, Johansson H, Borgstrom F, Strom O, McCloskey E. FRAX and its applications to clinical practice. Bone 2009;44:734-743.
28. Wells G, Tugwell P, Shea B, et al. Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev 2002;23:529-539.
29. Cauley JA, Robbins J, Chen Z, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA 2003;290:1729-1738.
30. Jackson RD, Wactawski-Wende J, LaCroix AZ, et al. Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the Women's Health Initiative randomized trial. J Bone Miner Res 2006;21:817-828.
31. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988;13:345-357.
32. Bagger YZ, Tanko LB, Alexandersen P, Qin G, Christiansen C. Early postmenopausal hormone therapy may prevent cognitive impairment later in life. Menopause 2005;12:12-17.
33. LeBlanc ES, Janowsky J, Chan BK, Nelson HD. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 2001; 285:1489-1499.
34. Znamensky V, Akama KT, McEwen BS, Milner TA. Estrogen levels regulate the subcellular distribution of phosphorylated Akt in hippocampal CA1 dendrites. J Neurosci 2003;23:2340-2347.
35. Wharton W, Gleason CE, Lorenze KR, et al. Potential role of estrogen in the pathobiology and prevention of Alzheimer's disease. Am J Transl Res 2009;1:131-147.
36. McCullough LD, Hurn PD. Estrogen and ischemic neuroprotection: an integrated view. Trends Endocrinol Metab 2003;14:228-235.
37. Xu H, Gouras GK, Greenfield JP, et al. Estrogen reduces neuronal generation of Alzheimer A-amyloid peptides. Nat Med 1998;4:447-451.
38. Tang M, Abplanalp W, Ayres S, Subbiah MT. Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation. Metabolism 1996;45:411-414.
39. Sawada H, Ibi M, Kihara T, et al. Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons. FASEB J 2000;14: 1202-1214.
40. McEwen B, Akama K, Alves S, et al. Tracking the estrogen receptor in neurons: implications for estrogen-induced synapse formation. Proc Natl Acad Sci USA 2001;98:7093-7100.
41. Luckhaus C, Mahabadi B, Grass-Kapanke B, et al. Blood biomarkers of osteoporosis in mild cognitive impairment and Alzheimer's disease. J Neural Transm 2009;116:905-911.
42. Michelson D, Stratakis C, Hill L, et al. Bone mineral density in women with depression. N Engl J Med 1996;335:1176-1181.
43. Modrego PJ, Ferrandez J. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Arch Neurol 2004;61:1290-1293.
44. Shiraki M, Shiraki Y, Aoki C, et al. Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res 1997;12:1438-1445.
45. Jonker C, Schmand B, Lindeboom J, Havekes LM, Launer LJ. Association between apolipoprotein E ?4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Arch Neurol 1998;55:1065-1069.
46. Barrett-Connor E, Edelstein SL, Corey-Bloom J, Wiederholt WC. Weight loss precedes dementia in community-dwelling older adults. J Am Geriatr Soc 1996;44:1147-1152.
47. Melton LJ III, Beard CM, Kokmen E, Atkinson EJ, O'Fallon WM. Fracture risk in patients with Alzheimer's disease. J Am Geriatr Soc 1994;42:614-619.
48. Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 2006;14:1032-1040.